Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Kidney donation does not increase the risk of cardiovascular disease for donors, research confirms The study, which was the first of its kind, has confirmed that donating a kidney does not have an adverse effect on a donor’s cardiovascular system or blood pressure for at least five years. It also confirms that having lower kidney function on its own does not increase the risk of cardiovascular disease.
Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment
News New research to find out what damage diabetes does to the smallest blood vessels of the heart in order to develop new therapies
Posted 11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
Posted 21 September 2021 Kidney donation does not increase the risk of cardiovascular disease for donors, research confirms The study has confirmed that donating a kidney does not have an adverse effect on a donor's cardiovascular system or blood pressure for at least five years.
Posted 31 August 2021 Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment Researchers at the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.
Posted 25 August 2021 Birmingham scientists discover new piece of clotting puzzle In research that provides a new perspective on how blood clotting works in infectious and inflammatory diseases, Birmingham scientists have described a potential new target and strategy for anti-thrombotic therapy.